Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Faron Pharmaceuticals
Faron Pharmaceuticals
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Regulatory
New patent protects the intravenous use of interferon-beta in a novel formulation
Faron has developed the first intravenous formulation of IFN-beta to enable the treatment of vascular leakage in lungs and other central organs
Manufacturing
Abzena to manufacture therapeutic antibody for Faron
Clevegen is a novel therapeutic antibody being developed by Faron to reduce immune suppression in cancer
Research & Development
Faron strengthens executive team by appointing new Medical Director
He will play a central role in expanding the Finnish firm's clinical programmes of drug candidates
Research & Development
Faron links up with Selexis to progress development of cancer antibody
Under the agreement, Faron will have access to the Selexis SUREtechnology platform and SURE CHO-M cell line
Ingredients
Rentschler to manufacture Traumakine for Faron
German contract manufacturer first produced product in 1980s
Subscribe now